PharmaCyte Biotech, Inc. - 14 Nov 2025 SCHEDULE 13D/A Report for Q/C TECHNOLOGIES, INC. Common Stock, par value $0.001 per share (QCLS)

Filing Manager: PharmaCyte Biotech, Inc.
Reporting Manager: PharmaCyte Biotech, Inc.
Security: Q/C TECHNOLOGIES, INC. Common Stock, par value $0.001 per share
Symbol: QCLS
Shares outstanding: 11,453,200 shares
Disclosed Ownership: 8,475,368 shares
Ownership: 74%
Form type: SCHEDULE 13D/A
Filing time: 18 Nov 2025, 16:29:55 UTC
Date of event: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
PharmaCyte Biotech, Inc.	74%	8,475,368	0	8,475,368	/s/ Carlos Trujillo	Carlos Trujillo	0001157075